ABSTRACT
Objectives
This study aims to examine the medical malpractice cases related to child mental health presented to Forensic Medicine Institution between 2018 and 2023, to identify the contributing factors leading to these cases, and to raise awareness among professionals in the field.
Materials and Methods
The malpractice case files of 17 cases evaluated at Forensic Medicine Institution between 2018 and 2023 were retrospectively reviewed. Data were obtained through a judicial information system and recorded using a systematic evaluation form.
Results
Of the psychiatric medical malpractice cases examined during the study period, 19.5% involved children and adolescents. The most common causes of malpractice claims were medication side effects (35.2%) and diagnostic and treatment errors (35.2%). The majority of claimants were fathers (58.8%). Malpractice claims were most frequently associated with psychiatrists (47.3%) and child and adolescent psychiatrists (21.0%).
Conclusion
Most of the medical malpractice cases in the field of child mental health are caused by medication side effects and diagnostic and treatment errors. Enhancing professionals’ awareness of ethical and legal responsibilities, and strengthening risk management, are critically important to prevent medical malpractice.
Keywords:
Child psychiatry, malpractice, medical errors, adverse effects, medication errors, medical liability
References
1Özer Ö, Taştan K, Set T, Çayır Y, Şener M. Tıbbi hatalı uygulamalar. Dicle Med J. 2015;42:394-397.
2Ash P. Malpractice in child and adolescent psychiatry. Child Adolesc Psychiatr Clin N Am. 2002;11:869-885.
3Smith S. Mental health malpractice in the 1990s. Houst Law Rev. 1991;28:209.
4Appelbaum PS. Malpractice claims in psychiatry: approaches to reducing risk. World Psychiatry. 2021;20:438-439.
5Frierson RL, Joshi KG. Malpractice law and psychiatry: an overview. Focus (Am Psychiatr Publ). 2019;17:332-336.
6Wagner KD, Pollard R, Wagner RF Jr. Malpractice litigation against child and adolescent psychiatry residency programs, 1981-1991. J Am Acad Child Adolesc Psychiatry. 1993;32:462-465.
7Nash L, Tennant C, Walton M. The psychological impact of complaints and negligence suits on doctors. Australas Psychiatry. 2004;12:278-281; discussion 282.
8Bellamy WA. Malpractice risks confronting the psychiatrist: a nationwide fifteen-year study of appellate court cases, 1946 to 1961. Am J Psychiatry. 1962;118:769-780.
9Cesur E, Taşdemir İ, Büyükakıncak E, Asliyüksek H, Turan Ş. Clinical characteristics and forensic psychiatric examination of cases evaluated due to alleged psychiatric medical malpractice. Turkish J Clin Psy. 2022;25:395-403.
10Kieling C, Baker-Henningham H, Belfer M, Conti G, Ertem I, Omigbodun O, Rohde LA, Srinath S, Ulkuer N, Rahman A. Child and adolescent mental health worldwide: evidence for action. Lancet. 2011;378:1515-1525.
11Karanges EA, Stephenson CP, McGregor IS. Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009-2012: focus on children, adolescents and prescriber specialty. Aust N Z J Psychiatry. 2014;48:917-931.
12Correll CU. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47:9-20.
13Frank B, Gupta S, McGlynn DJ. Psychotropic medications and informed consent: a review. Ann Clin Psychiatry. 2008;20:87-95.
14Jureidini J, Dunbar M. Medical malpractice: child and adolescent psychiatry. In: Payne-James J, Byard RW, Corey TS, Henderson C, editors. Encyclopedia of Forensic and Legal Medicine. 2nd ed. Oxford: Elsevier; 2016. p. 380-382.
15Sondheimer A. Ethics and risk management in administrative child and adolescent psychiatry. Child Adolesc Psychiatr Clin N Am. 2010;19:115-129.
16Mian AI, Milavić G, Skokauskas N. Child and adolescent psychiatry training: a global perspective. Child Adolesc Psychiatr Clin N Am. 2015;24:699-714.
17Shahidullah JD, Roberts H, Parkhurst J, Ballard R, Mautone JA, Carlson JS. State of the evidence for use of psychotropic medications in school-age youth. Children (Basel). 2023;10:1454.
18Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163:41-47.
19Rey JM, Martin A. Selective serotonin reuptake inhibitors and suicidality in juveniles: review of the evidence and implications for clinical practice. Child Adolesc Psychiatr Clin N Am. 2006;15:221-237.
20Spirito A, Overholser J. The suicidal child: assessment and management of adolescents after a suicide attempt. Child Adolesc Psychiatr Clin N Am. 2003;12:649-665.
21Jovanović A, Jasović-Gasić M, Lecić-Tosevski D. [Medicolegal aspects of hospital treatment of violent mentally ill persons]. Srp Arh Celok Lek. 2009;137:292-297. Serbian.
22Wettstein R. Specific issues in psychiatric malpractice. In: Rosner R, Scott C, editors. Principles and Practice of Forensic Psychiatry. 3rd ed. Boca Raton (FL): CRC Press (Taylor & Francis Group); 2017. p. 325-336.
23Ernstmeyer K, Christman E. Legal and ethical considerations in mental health care. In: Nursing: Mental Health and Community Concepts [Internet]. Eau Claire (WI): Chippewa Valley Technical College; 2022 [cited May 19, 2025]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK616992/
24Woody RH. Obtaining legal counsel for child and family mental health practice. Am J Fam Ther. 2008;36:323-331.
25Jonkman KM, Back E, Staal WG, Benard L, van der Doelen DM, Begeer S. Alternative treatments for autism: prevalence and predictors. Res Autism Spectr Disord. 2022;98:102046.
26Levy SE, Hyman SL. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2008;17:803-820.
27Cohen MH, Eisenberg DM. Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann Intern Med. 2002;136:596-603.
28Kels CG, Kels LH. Caveat promisor: the potential pitfalls of clinical guarantees. Am J Med. 2012;125:431-432.
